About Zoetis
Zoetis is a publicly listed company based in Brussels (Belgium) founded in 2012. Animal medicines, vaccines, and diagnostics are manufactured and supplied. It operates in the Healthcare and Agriculture sectors. Zoetis has completed 15 acquisitions, including Abaxis, Basepaws and Ethos Diagnostic Science. Its website zoetis.com draws about 310 thousand monthly visits. Zoetis offers products and services including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP. Its focus areas include Food and Agriculture Tech, Livestock Tech, Health Management and Pharmaceuticals. Its legal entity is Zoetis Services LLC.
Company details
Zoetis was founded in 2012 and is based in Brussels, Belgium. Operations focus on the animal health sector, where medicines, vaccines, and diagnostic products are developed and distributed for livestock including poultry, swine, sheep, horses, and cattle. Solutions target disease prevention and treatment in respiratory, gastrointestinal, and reproductive systems. Additional offerings include parasiticides, anti-infectives for microbial issues, medicinal feed additives, and products for pain management and sedation.
- Headquarters Brussels, Belgium
- Stage Public
- SectorsHealthcareAgriculture
- Website category Pets and Animals · Pet Food and Supplies
- Email••••••••
- Phone•••• ••••
- Website zoetis.com
- Social LinkedIn X Facebook YouTube
- Legal Name Zoetis Services Llc
- Latest Funding Round$15.3M (USD), Grant
Mar 2023
- InvestorsGates Foundation
& 1 more
- Investments & AcquisitionsAbaxis
& 14 more
Associated legal entities of Zoetis
Zoetis is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zoetis India Limited CIN U46497MH2007PLC203686 | Active | 06 Sep 2007 | Mumbai, Maharashtra | ₹402 Cr | 127 | 3 | View details |
| Zoetis Pharmaceutical Research Private Limited CIN U24117MH1995FTC084206 | Active | 02 Jan 1995 | Mumbai, Maharashtra | ₹595 Cr | 53 | 5 | View details |
Products & Services of Zoetis
Zoetis offers a comprehensive portfolio of products and services, including Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP.
Treatment for canine osteoarthritis pain relief
Protection against parasites in dogs
Manages allergic skin conditions in dogs
Therapy for pain in cats
Antibiotic for cattle respiratory diseases
Apps and channels of Zoetis
its YouTube channel Zoetis has 13.7K subscribers and 30 videos.
Videos from Zoetis
The most watched videos on Zoetis's YouTube channel, Zoetis (13.7K subscribers). Click a video to play it here.
More on Zoetis.
Funding Insights of Zoetis
- Total Rounds 9
- Last Round Grant — $15.3M
- First Round $64,610
(Apr 2015)
- Investors Count 2
All 9 funding rounds of Zoetis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $15.3M | Grant | – | – | |
| Jan 2023 | $49,342 | Grant | – | – | |
| May 2022 | $2.57M | Grant | – | – | – |
| Nov 2019 | $55,952 | Grant | – | – | |
| Sep 2019 | $122,504 | Grant | – | – | |
| Jul 2019 | $176,414 | Grant | – | – | |
| Sep 2018 | $205,386 | Grant | – | – | |
| Jun 2018 | Grant | – | – | ||
| Apr 2015 | $64,610 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Zoetis
Zoetis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gates Foundation and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Zoetis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Zoetis
The boards of the 2 registered companies of Zoetis currently have 7 directors; the longest-serving is Resha Mahabaleshwar Kantak, appointed in 2012. 44 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Resha Mahabaleshwar Kantak DIN 05247706 | Whole-time director | 06 Apr 2012 | 14 yrs 7 mo | Zoetis India Limited |
| Kavita Kirankumar Bhavnani DIN 01918076 | Director | 24 Nov 2012 | 13 yrs 11 mo | Zoetis Pharmaceutical Research Private Limited |
| Sudeepta Neogi DIN 09121301 | Whole-time director | 26 Mar 2021 | 5 yrs 7 mo | Zoetis Pharmaceutical Research Private Limited |
| Jaydip Chatterjee DIN 09704617 | Whole-time director | 12 Sep 2022 | 4 yrs 2 mo | Zoetis India Limited |
| Deepak Mohanlal Jain DIN 06598586 | Whole-time director | 14 Nov 2022 | 3 yrs 11 mo | Zoetis Pharmaceutical Research Private Limited |
| Anurag Sood DIN 07653286 | Whole-time director | 06 Mar 2023 | 3 yrs 8 mo | Zoetis Pharmaceutical Research Private Limited |
| Ashwini Shrikant Deshpande DIN 08548876 | Managing Director | 30 Sep 2023 | 3 yrs 1 mo | Zoetis India Limited |
People of Zoetis
1038 people are tracked at Zoetis (317 in leadership, 13 in board & advisors, 708 in team).
| Name | Role | Group |
|---|---|---|
James Henegan | Director For Salesforce Effectiveness, Leadership Development, And Sales Tools | Leadership |
John Drinkell | Director - Business Operations Effectiveness | Leadership |
Shelly Lettman | Communications Director | Leadership |
Michael Stegemann | Executive Director | Leadership |
Marcia Brito | Head Of Transformation | Leadership |
Dori Herczegh | Director, Sr. HRBP Canada & Latam | Leadership |
Alexis Martin | Human Resources Business Partner, Enabling Functions | Leadership |
Stacey F. | Associate Director | Leadership |
Kishore Prayaga | Senior Director | Leadership |
Betty Mason | Head Of Program Management, GMS Biologics Platform | Leadership |
Alexandra Hadfield | Associate Director, Partner Communications & Digital Lead | Leadership |
Tommy Brooks | Director, Head Of Sales | Leadership |
Julian Aymans | Vice President Global External Operations | Leadership |
Darren Remsburg | Associate Director, Veterinary Medical Information & Product Support | Leadership |
| Director Supply Chain & Logistics | Leadership | |
Todd Odonnell | Vice President Global Transformation | Leadership |
Doug Jenkins | Head Of U.s. Pricing, Contracting, And Customer Operations | Leadership |
Tomasz Dziechciarz | Senior Director, Global Trade Compliance | Leadership |
Joseph Morrin | Central Planning & Performance Lead - Director, Global External Supply | Leadership |
Carlos Martinez Moya | ZTD GMS Systems Lead & Business Partner - Olot | Leadership |
1018 more people are available in the full profile.
Complete people profiles for Zoetis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Zoetis
Zoetis is a publicly listed company on the NYSE with ticker symbol ZTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 Feb 2013
- Listed onNYSE: ZTS
- Listed entityZoetis Inc.
- Exchange sectorHealth technology
Financials of Zoetis
Figures of Zoetis Pharmaceutical Research Private Limited, the primary company behind Zoetis, for FY 2025. Revenue was ₹595 Cr (+28% year on year). Net profit was ₹41.59 Cr (7% margin). EBITDA was ₹106 Cr (18% margin). Revenue has grown at a compounded annual rate of +18% over three years and +12% over five years.
- ₹595 CrRevenue · FY 2025 · +28% YoY
- ₹41.59 CrNet profit · 7% margin
- ₹106 CrEBITDA · 18% margin
- ₹354 CrPaid-up capital
- 53Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Zoetis Pharmaceutical Research Private Limited are on its company page.
Detailed financial statements for Zoetis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zoetis
Zoetis has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Abaxis, Basepaws and Ethos Diagnostic Science.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of monoclonal antibody therapeutics for pets | petmedix.com | Babraham, United Kingdom | 2017 | Sep 2023 | •••• | |
Species-specific antibodies for pets are developed via a specialized platform. | adivo.vet | Planegg, Germany | 2018 | Sep 2023 | •••• | |
Instruments are developed to measure quality of life in animals. | newmetrica.com | Glasgow, United Kingdom | 2013 | Sep 2022 | •••• | |
Provider of genetic testing for cats | basepaws.com | Mountain View, United States | 2016 | Jun 2022 | •••• | |
Animal health products are provided by Jurox for veterinary care. | jurox.com | Maitland, Australia | 1971 | Aug 2021 | •••• | |
SaaS-based platform for veterinary professionals is developed and provided. | virtualrecall.com | Guildford, United Kingdom | 2011 | Jul 2020 | •••• | |
Veterinary healthcare products are developed and education services are provided. | ethosdiagnostics.com | San Diego, United States | 2015 | Feb 2020 | •••• | |
Provider of veterinary medicines, vaccines & diagnostic products supplying services | znlabs.com | Louisville, United States | 2017 | Nov 2019 | •••• | |
Veterinary laboratory services are provided as a standalone center. | phoenixlab.com | Mukilteo, United States | 1989 | Oct 2019 | •••• | |
Novel species-specific biologics for companion animals are developed and commercialized. | nexvet.com | Tullamore, Ireland | 2010 | •••• |
Complete acquisition details for Zoetis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zoetis
14 dated milestones of Zoetis across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Zoetis is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $65K.
- Acquisition Acquires Phoenix Lab.
- Acquisition Acquires ZNLabs Veterinary Diagnostics.
- Acquisition Acquires Ethos Diagnostic Science.
- Acquisition Acquires Virtual Recall.
- Acquisition Acquires Jurox.
- Acquisition Acquires Jurox.
- Acquisition Acquires Basepaws.
- Acquisition Acquires NewMetrica.
- Funding Latest funding round, Grant, of $15.3M.
- Acquisition Acquires adivo.
- Acquisition Acquires PetMedix.
Web traffic of Zoetis
The website of Zoetis (zoetis.com) receives about 310.3K visits a month and ranks #177,754 among all websites worldwide, #1,169 in Pet Food and Supplies.
- Monthly visits310.3K
▲ 19.7% vs previous month
- Unique visitors112.6K
per month
- Global rank#177,754
among all websites
- Category rank#1,169
Pets and Animals · Pet Food and Supplies
- Bounce rate45%
- Pages per visit2.4
- Average visit1 min 36 sec
- DevicesDesktop 64% · Mobile 36%
Websites whose visitors overlap most with Zoetis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zoetisus.com | 100% | #165,940 | View details | ||
zoetispetcare.com | zoetispetcare.com | 79% | #89,026 | – | |
| merial.com | 68% | View details | |||
| henryscheinvet.com | 62% | View details | |||
pattersonvet.com | pattersonvet.com | 56% | #335,483 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Zoetis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zoetis
Complete news archive for Zoetis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zoetis
Zoetis was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Zoetis is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.
Zoetis was founded in 2012 and is based in Brussels, Belgium. Operations focus on the animal health sector, where medicines, vaccines, and diagnostic products are developed and distributed for livestock including poultry, swine, sheep, horses, and cattle. Solutions target disease prevention and treatment in respiratory, gastrointestinal, and reproductive systems. Additional offerings include parasiticides, anti-infectives for microbial issues, medicinal feed additives, and products for pain management and sedation.
Zoetis offers Librela, Simparica TRIO, Apoquel, Solensia, and Draxxin KP.
Yes, Zoetis is publicly traded on NYSE under the ticker symbol ZTS.
Zoetis has made 15 acquisitions, including Abaxis, Basepaws, and Ethos Diagnostic Science.
Zoetis has 2 investors. Key investors include Gates Foundation, and European Union.
Zoetis is associated with 2 legal entities: Zoetis Pharmaceutical Research Private Limited, Zoetis India Limited.
The legal entities of Zoetis currently have 8 directors, including Anurag Sood, Sudeepta Neogi, Kavita Kirankumar Bhavnani and others.
The website of Zoetis receives about 310 thousand visits a month and ranks #177,754 among all websites worldwide.